Immunotherapy strategies in multiple myeloma

Area of Science:

• Oncology
• Immunology

Background:

• Multiple myeloma (MM) is a B-cell malignancy involving malignant plasma cell proliferation in bone marrow, leading to osteolytic bone lesions.
• MM serves as a model for successful cancer drug discovery and translational medicine.

Purpose of the Study:

• To discuss immunotherapy as a promising therapeutic strategy for multiple myeloma.
• To highlight the potential for immunotherapy to achieve effective and long-lasting treatment outcomes.

Main Methods:

• Review of preclinical and clinical studies on immunotherapy for multiple myeloma.
• Categorization of immunotherapy into passive and active approaches.
• Focus on immunotherapies targeting tumor-associated antigens.

Main Results:

• Immunotherapy targeting tumor-associated antigens has demonstrated encouraging results in various studies.
• Both passive and active immunotherapy approaches show potential for treating multiple myeloma.

Conclusions:

• Immunotherapy represents a significant and encouraging therapeutic avenue for multiple myeloma.
• Targeting tumor-associated antigens via immunotherapy offers a path toward durable responses in MM patients.